soyeon.park

01/18/2022

IVI and SK bioscience Complete Recruitment for Phase III Clinical Trial of SKBS’ COVID-19 Vaccine

Recruitment of global Phase III clinical trial of ‘GBP510’ completed, with vaccine expected to be authorized in the first half of 2022 A booster dose study is concurrently being planned to bring additional vaccine to the global COVID-19 vaccine market   January 19, 2022 SEOUL, […]
12/07/2021

IVI, ADB SEADS, IPK, ICARS, and the Danish Embassy in Korea launch webinar on combatting antimicrobial resistance

    The webinar “Curbing the Invisible Pandemic: Effective Solutions to Collectively Combat Antimicrobial Resistance” was held on December 7, 2021   December 7, 2021 — The International Vaccine Institute (IVI), Asian Development Bank Southeast Asia Development Solutions (ADB SEADS), Institut Pasteur Korea (IPK), the […]
12/03/2021

The 2022 IVI – SK bioscience Park MahnHoon Award

12/02/2021

Dr. Sushant Sahastrabuddhe of IVI named ‘Honorary Citizen of Seoul’

Cited for contributions to development of vaccines, joining 8 foreign residents to receive Honorary Citizenship in 2021 Second Honorary Seoul Citizen from IVI   SEOUL, Korea — Dr. Sushant Sahastrabuddhe, Associate Director General at the International Vaccine Institute (IVI), has been awarded “Honorary Citizenship of […]